Lipids attribution for controls and dengue groups according with Lipid Maps database, obtained via exploratory metabolomics from human serum.

Lipids attribution for controls and dengue groups according with Lipid Maps database, obtained via exploratory metabolomics from human serum.

<p>Lipids attribution for controls and dengue groups according with Lipid Maps database, obtained via exploratory metabolomics from human serum.</p>

Збережено в:

Бібліографічні деталі
Автор:	Ricardo E. Correa Fierro (22676430) (author)
Інші автори:	Noroska Gabriela Mogollón Salazar (22676433) (author), Washington B. Cárdenas (3213597) (author), Evencio Joel Medina-Villamizar (22676436) (author), Jefferson Pastuña-Fasso (22676439) (author), Melanie Ochoa-Ocampo (21222826) (author), Giovanna Morán-Marcillo (22676442) (author), Mary Ernestina Regato Arrata (22676445) (author), Mildred Zambrano (16641645) (author), Joyce Andrade (16641648) (author), Juan Chang (8280894) (author), Saurabh Mehta (367781) (author), Fernanda Bertuccez Cordeiro (16641642) (author)
Опубліковано:	2025
Предмети:	Biochemistry Medicine Microbiology Cell Biology Biotechnology Cancer Virology Biological Sciences not elsewhere classified Chemical Sciences not elsewhere classified receiver operating characteristic highest predictive power faster patient screening component 5 showing complex immune response serum lipid metabolome evaluate biomarker performance denv ), triggers serum lipidomics profiling new diagnostic tools div >< p disproportionately affects children assess group separation pediatric dengue fever dengue virus infection denv infected group dengue virus dengue fever lipid metabolism diagnostic methods diagnosis tools dengue research biomarker potential biomarker discovery z </ subtropical regions metabolic alterations may contribute mass spectrometry key role glycerol lipids fatty acids despite advancements curve analysis adolescents infected 68345 ). 15 ).
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!

Схожі ресурси

PLS-DA regression model from untargeted metabolomics of serum samples from children infected with dengue and controls.
за авторством: Ricardo E. Correa Fierro (22676430)
Опубліковано: (2025)

ROC curve analysis of a set of biomarkers obtained via untargeted metabolomics in serum samples from children infected with DENV compared to Control.
за авторством: Ricardo E. Correa Fierro (22676430)
Опубліковано: (2025)

Univariate ROC curves for individual analysis of the 15 <i>m/z</i> suggested as biomarkers.
за авторством: Ricardo E. Correa Fierro (22676430)
Опубліковано: (2025)

Workflow of untargeted metabolomics in serum samples from children infected with DENV.
за авторством: Ricardo E. Correa Fierro (22676430)
Опубліковано: (2025)

Supplementary Figure S1 from Serologic Profiling Using an Epstein-Barr Virus Mammalian Expression Library Identifies EBNA1 IgA as a Prediagnostic Marker for Nasopharyngeal Carcinoma
за авторством: Sarita Paudel (15047430)
Опубліковано: (2025)

Supplementary Figure S2 from Serologic Profiling Using an Epstein-Barr Virus Mammalian Expression Library Identifies EBNA1 IgA as a Prediagnostic Marker for Nasopharyngeal Carcinoma
за авторством: Sarita Paudel (15047430)
Опубліковано: (2025)

Supplementary Figure S3 from Serologic Profiling Using an Epstein-Barr Virus Mammalian Expression Library Identifies EBNA1 IgA as a Prediagnostic Marker for Nasopharyngeal Carcinoma
за авторством: Sarita Paudel (15047430)
Опубліковано: (2025)

Supplementary Figure S4 from Serologic Profiling Using an Epstein-Barr Virus Mammalian Expression Library Identifies EBNA1 IgA as a Prediagnostic Marker for Nasopharyngeal Carcinoma
за авторством: Sarita Paudel (15047430)
Опубліковано: (2025)

Supplementary Figure S5 from Serologic Profiling Using an Epstein-Barr Virus Mammalian Expression Library Identifies EBNA1 IgA as a Prediagnostic Marker for Nasopharyngeal Carcinoma
за авторством: Sarita Paudel (15047430)
Опубліковано: (2025)

Supplementary Figure S6 from Serologic Profiling Using an Epstein-Barr Virus Mammalian Expression Library Identifies EBNA1 IgA as a Prediagnostic Marker for Nasopharyngeal Carcinoma
за авторством: Sarita Paudel (15047430)
Опубліковано: (2025)

Data Sheet 1_Adaptive laboratory evolution enhances cell yield and lipid production of Chlorella sorokiniana under mildly cold conditions.pdf
за авторством: Shu-Yi Lu (22679327)
Опубліковано: (2025)

Figure 1 from Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms
за авторством: James R. Larkin (14936324)
Опубліковано: (2025)

Figure 2 from Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms
за авторством: James R. Larkin (14936324)
Опубліковано: (2025)

Figure 3 from Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms
за авторством: James R. Larkin (14936324)
Опубліковано: (2025)

Figure 4 from Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms
за авторством: James R. Larkin (14936324)
Опубліковано: (2025)

Figure 5 from Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms
за авторством: James R. Larkin (14936324)
Опубліковано: (2025)

Table 1 from Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms
за авторством: James R. Larkin (14936324)
Опубліковано: (2025)

A Four-Gene Signature from Blood to Exclude Bacterial Etiology of Lower Respiratory Tract Infection in Adults
за авторством: Edward E. Walsh (20760337)
Опубліковано: (2025)

Supplementary Table S3 from Circulating Exosomal PD-L1 at Initial Diagnosis Predicts Outcome and Survival of Patients with Osteosarcoma
за авторством: Jun Wang (15051911)
Опубліковано: (2025)

Lipid residency distributions during coarse-grained simulations of YbbAP.
за авторством: Martin B. L. McAndrew (22683641)
Опубліковано: (2025)

Molecular dynamics simulations of YbbAP suggest the periplasmic-side pocket is a lipid-binding site.
за авторством: Martin B. L. McAndrew (22683641)
Опубліковано: (2025)

Atomistic molecular dynamics simulation showing partial extraction of a lipid from the bilayer by YbbAP.
за авторством: Martin B. L. McAndrew (22683641)
Опубліковано: (2025)

Supplementary Figure S1 from Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients
за авторством: Javier Pascual (15018176)
Опубліковано: (2025)

Supplementary Figure S2 from Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients
за авторством: Javier Pascual (15018176)
Опубліковано: (2025)

Supplementary Figure S3 from Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients
за авторством: Javier Pascual (15018176)
Опубліковано: (2025)

Supplementary Figure S4 from Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients
за авторством: Javier Pascual (15018176)
Опубліковано: (2025)

Supplementary Figure S5 from Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients
за авторством: Javier Pascual (15018176)
Опубліковано: (2025)

Supplementary Table S2 from Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients
за авторством: Javier Pascual (15018176)
Опубліковано: (2025)

Supplementary Table S3 from Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients
за авторством: Javier Pascual (15018176)
Опубліковано: (2025)

Relationship between estimated probability of a dengue virus infection (DENV) found during model testing for Model 9 (incorporating paired IgG, IgM, GM HAI, and acute GM HAI serological data) and the number of serological assays (RT-PCR, HAI, and EIA) that interpret the individual as having an infection.
за авторством: Marco Hamins-Puértolas (15238661)
Опубліковано: (2025)

Table 1_Cross-species validation of a 6-miRNA blood signature for Parkinson’s disease: from MPTP mice to human PBMC and serum exosomes.docx
за авторством: Nagyum Jung (22686458)
Опубліковано: (2025)

Figure 1 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
за авторством: Nicola S. Meagher (15048462)
Опубліковано: (2025)

Figure 2 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
за авторством: Nicola S. Meagher (15048462)
Опубліковано: (2025)

Figure 3 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
за авторством: Nicola S. Meagher (15048462)
Опубліковано: (2025)

Supplementary Tables S1-S11 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
за авторством: Nicola S. Meagher (15048462)
Опубліковано: (2025)

Table 1 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
за авторством: Nicola S. Meagher (15048462)
Опубліковано: (2025)

Table 2 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
за авторством: Nicola S. Meagher (15048462)
Опубліковано: (2025)

Table 3 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
за авторством: Nicola S. Meagher (15048462)
Опубліковано: (2025)

Spearman correlation coefficient (r<sub>s</sub>) between echocardiographic measurements (i.e., left atrial:aortic root diameter; LA:Ao), markers of loss of GI barrier function (i.e., lipopolysaccharide; LPS), and cardiac (i.e., troponin) and systemic (i.e., cytokines) inflammation in 36 dogs with untreated myxomatous mitral valve disease (MMVD).
за авторством: Maria C. Jugan (18928389)
Опубліковано: (2025)

Association between Exposures of Interest with Serum Lipopolysaccharide and Troponin Concentrations Based on Univariable Models‡ in 36 Client-owned Dogs with Untreated Myxomatous Mitral Valve Disease (MMVD).
за авторством: Maria C. Jugan (18928389)
Опубліковано: (2025)

Cannot write session to /tmp/vufind_sessions/sess_cfos0eat36b4ehif7st94d7p3c